Symptomatic Trichomonas vaginalis infection in the setting of severe nitroimidazole allergy: Successful treatment with boric acid

Sexual Health

Volumn 9, Issue 4, 2012, Pages 389-391

  Muzny, Christina ^a   Barnes, Arti ^b   Mena, Leandro ^b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

clotrimazole; furazolidone; hypersensitivity; nitazoxanide; povidone iodine

Indexed keywords

BORIC ACID; CLINDAMYCIN; CLOTRIMAZOLE; FURAZOLIDONE; METRONIDAZOLE; NITAZOXANIDE; PAROMOMYCIN; POVIDONE IODINE;

ADULT; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; SEXUAL BEHAVIOR; SEXUALITY; TREATMENT DURATION; TREATMENT OUTCOME; TRICHOMONIASIS; VAGINA DISCHARGE; VAGINAL BURNING SENSATION; VAGINAL PRURITUS;

ADMINISTRATION, INTRAVAGINAL; ADULT; BORIC ACIDS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; NITROIMIDAZOLES; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS;

EID: 84865010182     PISSN: 14485028     EISSN: 14498987     Source Type: Journal    
DOI: 10.1071/SH11114     Document Type: Article

References (26)

1. Forna F, Gülmezoglu AM. Interventions for treating trichomoniasis in women. Cochrane Database Syst Rev 2003; (2): CD000218.
2. Soper D. Trichomoniasis: Under control or undercontrolled? Am J Obstet Gynecol 2004; 190: 281-90. doi:10.1016/j.ajog.2003.08.023
3. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2010. MMWR Morb Mortal Wkly Rep 2010; 59: 1-110.
4. Pearlman MD, Yashar C, Ernst S, Solomon W. An incremental dosing protocol for women with severe vaginal trichomoniasis and adverse reactions to metronidazole. Am J Obstet Gynecol 1996; 174: 934-6. doi:10.1016/S0002-9378(96) 70329-0
5. Kurohara ML, Kwong FK, Lebherz TB, Klaustermeyer WB. Metronidazole hypersensitivity and oral desensitization. J Allergy Clin Immunol 1991; 88: 279-80. doi:10.1016/0091-6749(91)90341-K
6. Helms DJ, Mosure DJ, Secor WE, Workowski KA. Management of Trichomonas vaginalis in women with suspected metronidazole hypersensitivity. Am J Obstet Gynecol 2008; 198: 370.e1-7. doi:10.1016/j.ajog.2007.10.795
7. Cedillo-Rivera R, Chavez B, Gonzalez-Robles A, Tapia A, Yepez- Mulia L. In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis, and Trichomonas vaginalis trophozoites. J Eukaryot Microbiol 2002; 49: 201-8. doi:10.1111/ j.1550-7408.2002.tb00523.x
8. Wright JM, Dunn LA, Kazimierczuk Z, Burgess AG, Krauer KG, Upcroft P, et al. Susceptibility in vitro of clinically metronidazoleresistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-20-deoxyadenosine. Parasitol Res 2010; 107: 847-853. doi:10.1007/s00436-010-1938-3
9. Blaha C, Duchene M, Aspock H, Walochnik J. In vitro activity of hexadecylphosphocholine (miltefosine) against metronidazoleresistant and -susceptible strains of Trichomonas vaginalis. J Antimicrob Chemother 2006; 57: 273-8. doi:10.1093/jac/dki417
10. Narcisi EM, Secor WE. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis. Antimicrob Agents Chemother 1996; 40: 1121-5.
11. Dan M, Sobel J. Failure of nitazoxanide to cure trichomonas in three women. Sex Transm Dis 2007; 34: 813-4.
12. Goldman LM, Upcroft JA, Workowski KA, Rapkin A. Treatment of metronidazole-resistant Trichomonas vaginalis. Sex Health 2009; 6: 345-7. doi:10.1071/SH09064
13. Nyirjesy P, Sobel JD, Weitz MV, Leaman DJ, Gelone SP. Difficult-totreat trichomoniasis: Results with paromomycin cream. Clin Infect Dis 1998; 26: 986-8. doi:10.1086/513951
14. Wong CA, Wilson D, Chew TA. Povidone-iodine in the treatment of metronidazole-resistant Trichomonas vaginalis. Aust N Z J Obstet Gynaecol 1990; 30: 169-71. doi:10.1111/j.1479-828X.1990. tb03255.x
15. Livengood CH III, Lossick JG. Resolution of resistant vaginal trichomoniasis associated with the use of intravaginal nonoxynol-9. Obstet Gynecol 1991; 78: 954-6.
16. Aggarwal A, Shier RM. Recalcitrant Trichomonas vaginalis infections successfully treated with vaginal acidification. J Obstet Gynaecol Can 2008; 30: 55-8.
17. Bedi RS. Metronidazole-induced asthma. Indian J Chest Dis Allied Sci 1991; 33: 213-5.
18. Kurohara ML, Kwong FK, Lebherz TB, Klaustermeyer WB. Metronidazole hypersensitivity and oral desensitization. J Allergy Clin Immunol 1991; 88: 279-280. doi:10.1016/0091-6749(91)90341-K
19. Añíbarro B, Fontela JL. Immediate rhinoconjunctivitis induced by metamizole and metronidazole. Ann Allergy Asthma Immunol 1997; 78: 345-6. doi:10.1016/S1081-1206(10)63194-8
20. Knowles S, Choudhury T, Shear NH. Metronidazole hypersensitivity. Ann Pharmacother 1994; 28: 325-6.
21. Asensio Sánchez T, Dávila I, Moreno E, Laffond E, Macías E, Ruiz A, et al. Anaphylaxis due to metronidazole with positive skin prick test. J Investig Allergol Clin Immunol 2008; 18: 138-9.
22. Porapakkham S. Metronidazole treatment of vaginal trichomoniasis. II. Oral vs. vaginal therapy. Obstet Gynecol 1967; 29: 213-6.
23. Krieger JN, Anagonou S. Trichomonas vaginalis and trichomoniasis. In Holmes KK, Sparling PF, Mardh PA, et al., eds. Sexually transmitted diseases. 3rd edn. New York: McGraw-Hill; 1999. pp. 587-604.
24. Petrin D, Delgaty K, Bhatt R, Garber G. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 1998; 11: 300-317.
25. Garber GE, Lemchuk-Favel LT, Bowie WR. Isolation of a celldetaching factor of Trichomonas vaginalis. J Clin Microbiol 1989; 27: 1548-53.
26. Pindak FF, Gardner WA Jr, Mora De Pindak M. Growth and cytopathogenicity of Trichomonas vaginalis in tissue cultures. J Clin Microbiol 1986; 23: 672-8.